Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_945a4af8e8a03b3b3b3359d02ea40846 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f5cbe15354be696ed8bb99d2de910b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfab307072eb33d3372c0cc35dec2dab http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3662ce5995dada5ea3d9873552592af0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88ea4c1a10bbb66bb592f1827f209b51 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6876 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6844 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2010-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21cc33c38509e485aaf53027cb51b298 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0daed224a8fec8f76b7cf7ebfedaa3e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fabc66416943e73832baade13c5384d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c659ecb5335b1936d48bf5b0398c806c |
publicationDate |
2015-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9150927-B2 |
titleOfInvention |
Quantification of IR-A and IR-B for tumor classification |
abstract |
Without limitation, this disclosure relates to compositions and methods for detecting and quantifying the expression of insulin receptor isoform A (IR-A) and/or insulin receptor isoform B (IR-B) in a tissue sample. The disclosure also relates to methods of diagnosis and classification based at least in part upon detecting and quantifying the expression of insulin receptor isoform A (IR-A) and/or insulin B (IR-B) in a tissue sample. Methods of treating a subject based upon such a classification are among additional aspects of the disclosure presented herein. |
priorityDate |
2009-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |